Oxford-founded biopharmaceutical development instrument manufacturer Refeyn has secured funding from the university and OSI to help scale manufacturing and distribution.
Refeyn, a UK-based molecular measurement instrument developer spun out of University of Oxford, has secured £2.6m ($3.4m) in a round backed by the university and its venture fund, Oxford Science Innovations.
The round featured Foresight Williams Technology EIS Fund, an investment vehicle backed by Williams Advanced Engineering, a subsidiary of racing car and engineering company Williams Group. The fund is managed by private equity firm Foresight.
Founded in April 2018 as Arago Biosciences, Refeyn is developing instruments for…
